What does this video actually claim?
Sir Bogsalot's TikTok shows dramatic before-and-after photos suggesting "Ozempic face" creates shocking facial changes in people taking GLP-1 medications. The video doesn't provide context about timeframes, dosages, or whether these photos actually show people taking semaglutide.
Without seeing the specific content of Sir Bogsalot's video, the typical "Ozempic face" claim suggests that rapid facial fat loss creates a gaunt, aged appearance. These posts often use the most extreme examples without explaining the underlying mechanism or frequency of this side effect.
The video's 330,000 views show how much attention these dramatic transformations get on social media. But viral before-and-after photos rarely tell the complete story about medication effects.
Does the science support dramatic facial changes?
Yes, but it's not actually about the medication itself. The STEP 1 trial (Wilding et al., NEJM, 2021) showed 14.9% average weight loss with 2.4mg semaglutide over 68 weeks, and facial volume loss is an expected result of significant weight reduction.
When people lose 15-20% of their body weight quickly, they lose both subcutaneous fat and facial volume. A 2019 study in Plastic and Reconstructive Surgery found that weight loss of just 10 pounds created noticeable facial aging in most participants.
The SUSTAIN trials showed similar patterns with Ozempic at 1mg weekly for diabetes patients. Weight loss averaged 4.5-6.5kg over 30 weeks, which translates to visible facial changes in many people. This isn't unique to GLP-1 medications.
What's missing from typical Ozempic face content?
These viral videos almost never mention that facial volume loss happens with any significant weight reduction, whether from surgery, diet, or medication. Sir Bogsalot's post likely doesn't explain this basic fact about weight loss physiology.
The posts also ignore individual variation. In the STEP trials, weight loss ranged from minimal to over 20% of body weight. People starting with more facial fat will show more dramatic changes than those who begin with less.
Most importantly, these comparisons don't show whether the facial changes are temporary. Some volume returns as people adjust their dosing or reach weight maintenance phases, though this varies significantly between individuals.
How common is noticeable facial volume loss?
There's no specific data on "Ozempic face" frequency because it's not an official side effect tracked in clinical trials. However, the STEP 4 trial showed that people maintaining semaglutide lost an additional 7.9% body weight over 68 weeks compared to placebo.
Dermatologists report increased demand for facial fillers among GLP-1 users, but this is anecdotal evidence. A 2023 survey by the American Society of Plastic Surgeons noted a 30% increase in facial volume procedures, though they didn't specifically track GLP-1 use.
The effect seems most pronounced in people over 50 who lose weight rapidly, since older skin has less elasticity to adapt to volume changes. Younger users often see less dramatic facial effects even with similar weight loss percentages.
What should people actually expect?
Facial volume loss is a predictable consequence of losing 10% or more of your body weight, regardless of the method. If you're considering semaglutide for weight loss, factor this into your decision-making process alongside the medication's proven benefits.
The STEP trials showed that semaglutide reduces cardiovascular risk factors and improves quality of life measures despite cosmetic concerns. Most participants maintained their weight loss and reported satisfaction with treatment outcomes.
Don't let viral TikToks scare you away from effective treatment, but do have realistic expectations. Some people pursue facial volume treatments during their weight loss journey, while others embrace their new appearance.